COSMOS Pharmaceutical (COSMOS Pharmaceutical) Total Liabilities : $1,377 Mil (As of Feb. 2024)

View and export this data going back to 2014. Start your Free Trial

What is COSMOS Pharmaceutical Total Liabilities?

COSMOS Pharmaceutical's Total Liabilities for the quarter that ended in Feb. 2024 was $1,377 Mil.

COSMOS Pharmaceutical's quarterly Total Liabilities declined from Aug. 2023 ($1,518.35 Mil) to Nov. 2023 ($1,438.18 Mil) and declined from Nov. 2023 ($1,438.18 Mil) to Feb. 2024 ($1,376.60 Mil).

COSMOS Pharmaceutical's annual Total Liabilities declined from May. 2021 ($1,564.81 Mil) to May. 2022 ($1,339.13 Mil) but then increased from May. 2022 ($1,339.13 Mil) to May. 2023 ($1,531.49 Mil).

COSMOS Pharmaceutical Total Liabilities Historical Data

The historical data trend for COSMOS Pharmaceutical's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

COSMOS Pharmaceutical Total Liabilities Chart

COSMOS Pharmaceutical Annual Data

Trend

May14

May15

May16

May17

May18

May19

May20

May21

May22

May23

Total Liabilities

Get a 7-Day Free Trial

1,339.19

1,628.81

1,564.81

1,339.13

1,531.49

COSMOS Pharmaceutical Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Total Liabilities	Get a 7-Day Free Trial															1,303.31	1,531.49	1,518.35	1,438.18	1,376.60

COSMOS Pharmaceutical Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

COSMOS Pharmaceutical's Total Liabilities for the fiscal year that ended in May. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1401.303	+	(100.078	+	18.168
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	11.937)
	=	1,531

Total Liabilities	=	Total Assets (A: May. 2023 )	-	Total Equity (A: May. 2023 )
	=	3071.559	-	1540.073
	=	1,531

COSMOS Pharmaceutical's Total Liabilities for the quarter that ended in Feb. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	1266.885	+	(53.217	+	44.521
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	11.977)
	=	1,377

Total Liabilities	=	Total Assets (Q: Feb. 2024 )	-	Total Equity (Q: Feb. 2024 )
	=	2875.654	-	1499.054
	=	1,377

COSMOS Pharmaceutical Total Liabilities Related Terms

Thank you for viewing the detailed overview of COSMOS Pharmaceutical's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

COSMOS Pharmaceutical (COSMOS Pharmaceutical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » COSMOS Pharmaceutical Corp (OTCPK:CSMYF) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

3349:Japan

Address

4 floor,10th first Fukuoka S Building Museum, Hakataekihigashi 2-chome,, Fukuoka, JPN, 812-0013

Website

http://www.cosmospc.co.jp

COSMOS Pharmaceutical Corp manages retail drugstores in Japan. The company places a strong emphasis on convenience regarding its product selection, which includes medical products, health and beauty aids, personal-care items, discount cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, alcoholic beverages, tobacco, insect repellent, and miscellaneous everyday consumables. The majority of the company's revenue is derived from common grocery sales. Cosmos also operates a private grocery brand called ON 365.

COSMOS Pharmaceutical (COSMOS Pharmaceutical) Headlines

From GuruFocus

Wasatch International Growth Fund Comments on CosmosPharmaceutical Corp

By Holly LaFon Holly LaFon • 09-25-2015

Matthews Japan Fund Reduces Stake in COSMOS

By Kyle Ferguson Kyle Ferguson • 08-12-2016

Wasatch International Growth Fund Comments on Cosmos Pharmaceutical

By Vera Yuan Vera Yuan • 10-30-2014

Hennessy Japan Small Cap Fund Adds 5 Stocks to Portfolio

By Sydnee Gatewood Sydnee Gatewood • 01-10-2020

Hennessy Japan Small Cap Fund Enters Macromill Holding, Boosts Tsubakimoto Chain Position

By Sydnee Gatewood • 04-05-2022